&nbsp;

PSQI2020-TechnicalAppendix-FR.pdf

Oct 2020

Document

PSQI2020-WebSlideshow-FR.PPTX

Oct 2020

Regimen

ACAL

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Funding:

Exceptional Access Program

acalabrutinib - For the treatment of adult patients with chronic lymphocytic leukemia (CLL), according to clinical criteria

Drugs Used:

acalabrutinib

Quick Link(s):

Regimen Monograph

Jul 2024

Regimen

ACAL+OBIN

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Drugs Used:

acalabrutinib (Unfunded),

oBINutuzumab (Unfunded)

Quick Link(s):

Regimen Monograph

Oct 2020

Regimen

ACAL(MNT)

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Drugs Used:

acalabrutinib (Unfunded)

Quick Link(s):

Regimen Monograph

Oct 2020

Plan des voies pathologiques du cancer de la peau

Document

PCC_4114_FNIMuI_ExecSummary_Inuktitut.pdf

Nov 2020

Document

PCC_4114_FNIMuI_ExecSummary_Ojibway.pdf

Nov 2020

Document

PCC_4114_FNIMuI_ExecSummary_Oji-Cree.pdf

Nov 2020

Document

plansPrintBtnIconPurple2.png

Nov 2020

Document

plansPrintBtnIconPurple3.png

Nov 2020

Regimen

ALPEFLVS

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

fulvestrant

Drugs Used:

fulvestrant,

alpelisib (Unfunded)